Testing can help identify or evaluate the following:
Neck & Shoulder Pain
Carpal Tunnel Syndrome
Nerve damage or destruction can result in:
Epidermal Nerve Fiber Density (ENFD)
In addition to NCV testing, your practice may qualify for Epidermal Nerve Fiber Density (ENFD) testing. ENFD testing a highly sensitive, skin biopsy, used to identify Small Fiber Neuropathy (SFN). SFN is a disorder of the peripheral nerves that affect somatic fibers, automatic fibers, or both, resulting gin sensory changes and or autonomic dysfunction when both types of fibers are involved. ENFD testing is the most reliable tool and considered the “Gold Standard for Testing” when diagnosing SFN. ENFD testing provides a definitive diagnosis, which assists the provider in treating and monitoring the prescribed regimen.
Patients presenting with pain, numbness, and paresthesia, are approbate for ENFD testing. Patients with diabetes mellitus, prediabetes, metabolic syndrome, fibromyalgia autoimmune disease, alcohol abuse, and idiopathic neuropathy are candidates, based on their presenting symptomatology. We provide an assessment survey to assist in the screening process to help identify appropriate patients for the skin punch biopsy.
Managing the Program
MedX provides an ancillary revenue opportunity to the physician’s office.
No investment in equipment, which typically runs around 150K
No staffing or liability issues
Patients get tested much quicker
Ancillary billing opportunities for the physician office
Accepted Insurances: Commercial, workers’ compensation, and auto injuries (PIP)
MedX Sales will manage your NCV Testing Program and provide reports needed to stay organized. Incorporating NCV Testing will improve the financial performance of your medical practice and patient outcomes.